首页> 外国专利> ENHANCED ARTEMISININ-BASED COMBINATION THERAPY FOR TREATING PARASITIC MEDIATED DISEASE

ENHANCED ARTEMISININ-BASED COMBINATION THERAPY FOR TREATING PARASITIC MEDIATED DISEASE

机译:基于青蒿素的增强联合疗法治疗寄生虫介导的疾病

摘要

The present invention describes a method of treating individuals suffering from microbial infections, including a parasitic disease such as malaria, by using an improved Artemisinin Combination Therapy (ACT), known as ActRx Tri-ACT Plus. The improved ACT therapy includes administering a combination of four drugs. In one embodiment of the present invention, the method includes administering to an individual a first composition comprising a therapeutically effective amount of an artemether spray sublingually. The individual is then administered a second composition, a therapeutically effective amount of artesunate. A third composition, an effective amount of berberine, or its pharmaceutically acceptable derivatives or salts is administered to the individual. A fourth composition, an effective amount of primaquine, or its pharmaceutically acceptable derivatives or salts is administered to the individual.
机译:本发明描述了一种通过使用称为ActRx Tri-ACT Plus的改良青蒿素联合疗法(ACT)来治疗遭受包括寄生虫病例如疟疾在内的微生物感染的个体的方法。改进的ACT疗法包括施用四种药物的组合。在本发明的一个实施方案中,该方法包括向个体舌下施用包含治疗有效量的蒿甲醚喷雾剂的第一组合物。然后给个体施用第二组合物,即治疗有效量的青蒿琥酯。将第三种组合物,有效量的小ber碱或其药学上可接受的衍生物或盐施用于个体。将第四种组合物,有效量的伯氨喹或其药学上可接受的衍生物或盐施用于个体。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号